Ask a Question

User relishlawyer1

Member for: 2 years (since Jan 27, 2023)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/kpt-330.html
About: Long-Term Overall Success From KEYNOTE-021 Cohort Gary: Pemetrexed along with Carboplatin Without or with Selinexor because First-Line Remedy with regard to Innovative Nonsquamous NSCLC

Activity by relishlawyer1

Score: 100 points (ranked #10)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for relishlawyer1

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...